Business Description
Dizal Pharmaceutical Co Ltd
ISIN : CNE1000055W8
Share Class Description:
SHSE:688192: Class ATotal Employee Number:
1,009Compare
Compare
Traded in other countries / regions
688192.China Index Membership
SSE Composite IndexCSI 500 Index IPO Date
2021-12-10Description
Dizal Pharmaceutical Co Ltd, formerly Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.34 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.17 | |||||
Debt-to-EBITDA | -2.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.85 | |||||
Beneish M-Score | -0.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 3.6 | |||||
3-Year EPS without NRI Growth Rate | 0.9 | |||||
3-Year FCF Growth Rate | -0.5 | |||||
3-Year Book Growth Rate | -13.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 56.18 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.06 | |||||
9-Day RSI | 69.53 | |||||
14-Day RSI | 67.19 | |||||
3-1 Month Momentum % | -38.03 | |||||
6-1 Month Momentum % | -46.09 | |||||
12-1 Month Momentum % | -45.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.82 | |||||
Quick Ratio | 2.78 | |||||
Cash Ratio | 2.47 | |||||
Days Inventory | 362.04 | |||||
Days Sales Outstanding | 46.47 | |||||
Days Payable | 1704.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.2 | |||||
Shareholder Yield % | -0.66 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.81 | |||||
Operating Margin % | -74.62 | |||||
Net Margin % | -74.62 | |||||
EBITDA Margin % | -71.52 | |||||
FCF Margin % | -87.99 | |||||
OCF Margin % | -73.5 | |||||
ROE % | -59.44 | |||||
ROA % | -23.83 | |||||
ROIC % | -50.94 | |||||
3-Year ROIIC % | 3.56 | |||||
ROC (Joel Greenblatt) % | -182.14 | |||||
ROCE % | -33.36 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 31.32 | |||||
PB Ratio | 23.14 | |||||
Price-to-Tangible-Book | 33.75 | |||||
EV-to-EBIT | -43.92 | |||||
EV-to-EBITDA | -43.92 | |||||
EV-to-Revenue | 31.41 | |||||
EV-to-FCF | -35.7 | |||||
Price-to-GF-Value | 0.45 | |||||
| Price-to-Net-Current-Asset-Value | 66.76 | |||||
| Price-to-Net-Cash | 186.12 | |||||
Earnings Yield (Greenblatt) % | -2.28 | |||||
FCF Yield % | -2.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Dizal Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 894.016 | ||
| EPS (TTM) (¥) | -1.46 | ||
| Beta | 0.859 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.33 | ||
| Volatility % | 44.65 | ||
| 14-Day RSI | 67.19 | ||
| 14-Day ATR (¥) | 4.833186 | ||
| 20-Day SMA (¥) | 46.907 | ||
| 12-1 Month Momentum % | -45.25 | ||
| 52-Week Range (¥) | 35.73 - 86.18 | ||
| Shares Outstanding (Mil) | 465.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dizal Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dizal Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dizal Pharmaceutical Co Ltd Frequently Asked Questions
What is Dizal Pharmaceutical Co Ltd(SHSE:688192)'s stock price today?
The current price of SHSE:688192 is ¥61.42. The 52 week high of SHSE:688192 is ¥86.18 and 52 week low is ¥35.73.
When is next earnings date of Dizal Pharmaceutical Co Ltd(SHSE:688192)?
The next earnings date of Dizal Pharmaceutical Co Ltd(SHSE:688192) is .
Does Dizal Pharmaceutical Co Ltd(SHSE:688192) pay dividends? If so, how much?
Dizal Pharmaceutical Co Ltd(SHSE:688192) does not pay dividend.
Press Release
Articles on Dizal Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers